Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.

Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS.

Clin Exp Allergy. 2006 Dec;36(12):1575-83.

PMID:
17177681
2.

Distinct spatial requirement for eosinophil-induced airways hyperreactivity.

Webb DC, McKenzie AN, Matthaei KI, Rothenberg ME, Foster PS.

Immunol Cell Biol. 2001 Apr;79(2):165-9. Review.

3.

Elemental signals regulating eosinophil accumulation in the lung.

Foster PS, Mould AW, Yang M, Mackenzie J, Mattes J, Hogan SP, Mahalingam S, Mckenzie AN, Rothenberg ME, Young IG, Matthaei KI, Webb DC.

Immunol Rev. 2001 Feb;179:173-81. Review.

PMID:
11292021
4.

IL-5-induced airway eosinophilia--the key to asthma?

Hamelmann E, Gelfand EW.

Immunol Rev. 2001 Feb;179:182-91. Review.

PMID:
11292022
5.

Chemokines in asthma: cooperative interaction between chemokines and IL-13.

Zimmermann N, Hershey GK, Foster PS, Rothenberg ME.

J Allergy Clin Immunol. 2003 Feb;111(2):227-42; quiz 243. Review.

PMID:
12589338
6.

Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin.

Mattes J, Foster PS.

Curr Drug Targets Inflamm Allergy. 2003 Jun;2(2):169-74. Review.

PMID:
14561170
7.

IL-13 as a therapeutic target for respiratory disease.

Kasaian MT, Miller DK.

Biochem Pharmacol. 2008 Jul 15;76(2):147-55. doi: 10.1016/j.bcp.2008.04.002. Review.

PMID:
18502398
8.

[Functional molecules in allergic bronchial asthma].

Tanaka H.

Yakugaku Zasshi. 2002 Sep;122(9):637-42. Review. Japanese.

9.

Interleukin 25 in allergic airway inflammation.

Tamachi T, Maezawa Y, Ikeda K, Iwamoto I, Nakajima H.

Int Arch Allergy Immunol. 2006;140 Suppl 1:59-62. Review.

PMID:
16772729
10.

Cytokines and chemoattractants in allergic inflammation.

Romagnani S.

Mol Immunol. 2002 May;38(12-13):881-5. Review.

PMID:
12009564
11.

Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease.

Jeffery PK.

Novartis Found Symp. 2001;234:149-61; discussion 161-8. Review.

PMID:
11199094
12.

IL-13 receptors and signaling pathways: an evolving web.

Hershey GK.

J Allergy Clin Immunol. 2003 Apr;111(4):677-90; quiz 691. Review.

PMID:
12704343
13.

Pathological role of IL-6 in the experimental allergic bronchial asthma in mice.

Doganci A, Sauer K, Karwot R, Finotto S.

Clin Rev Allergy Immunol. 2005 Jun;28(3):257-70. Review.

PMID:
16129910
14.

Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.

Lai HY, Rogers DF.

Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):67-76. doi: 10.1097/ACI.0b013e328334643a. Review.

PMID:
19907312
15.

Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma.

Corry DB, Kheradmand F.

Am J Respir Med. 2002;1(3):185-93. Review.

PMID:
14720056
16.

Airway hyperresponsiveness: a story of mice and men and cytokines.

Townley RG, Horiba M.

Clin Rev Allergy Immunol. 2003 Feb;24(1):85-110. Review.

PMID:
12644720
17.

Understanding the pathogenesis of allergic asthma using mouse models.

Leong KP, Huston DP.

Ann Allergy Asthma Immunol. 2001 Aug;87(2):96-109; quiz 110,. Review.

PMID:
11527255
18.

Interleukin-4 receptor signaling pathways in asthma pathogenesis.

Chatila TA.

Trends Mol Med. 2004 Oct;10(10):493-9. Review.

PMID:
15464449
19.

The transcriptional regulator NFIL3 controls IgE production.

Rothman PB.

Trans Am Clin Climatol Assoc. 2010;121:156-71; discussion 171. Review.

20.

The genetics of allergen-induced airway hyperresponsiveness in mice.

Wills-Karp M, Ewart SL.

Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 2):S89-96. Review.

PMID:
9351586
Items per page

Supplemental Content

Support Center